TrialCPT: pharmacometrics & systems pharmacology2022

An exposure-response analysis of ponesimod clinical efficacy in a randomized phase III study in patients with relapsing multiple sclerosis.

Belén Valenzuela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.